Bioactive Fraction LCS2 from Litchi (Litchi chinensisSonn.) Seed By-Product Attenuates LPS-Induced Acute Prostatic Inflammatory Injury via Modulating NF-κB and MAPK Signaling Pathways
Open Access
Abstract
Litchi seed is a major by-product of the litchi processing industry, rich in polyphenols and flavonoids with documented anti-inflammatory properties. Prostatic inflammatory injury remains a prevalent male health concern, and dietary intervention with natural bioactive components represents a promising strategy for prostate health maintenance. This study investigated the protective efficacy of LCS2, a bioactive fraction isolated from litchi seed by-product, against lipopolysaccharide (LPS)-induced prostatic inflammatory injury in rats and explored its underlying mechanisms. LCS2 was obtained via extraction, purification, and activity screening, and its chemical profile was characterized by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). Its anti-inflammatory activity and pathway regulatory effects were evaluated in LPS-stimulated RAW264.7 macrophages and further verified in a rat model of LPS-induced acute prostatic inflammation. A total of 26 compounds, mainly flavonoids, polyphenols, and tannins, were tentatively identified in LCS2. In vitro, LCS2 pretreatment with LCS2 at concentrations up to 40 μg/mL dose-dependently suppressed LPS-induced overproduction of nitric oxide (NO) and reactive oxygen species (ROS), reduced pro-inflammatory cytokine mRNA levels, and downregulated iNOS and COX-2 protein expression. In vivo, 7-day dietary pretreatment with LCS2 at doses up to 100 mg/kg ameliorated prostate histopathological injury, reduced peripheral inflammatory cell counts, and decreased inflammatory mediator levels in serum and prostate tissue by inhibiting NF-κB and MAPK pathway activation. These findings support the high-value valorization of litchi seed by-product and highlight the potential of LCS2 for further development as a bioactive component for prostate health applications.Keywords
Funding Information
- National Natural Science Foundation of China (82160775)
- Key Projects of Guangxi Natural Science Foundation (2021GXNSFDA075008)
- Doctoral Startup Fund Project of Guizhou University of Traditional Chinese Medicine (2025-01)
- Guizhou Provincial Science and Technology Innovation Leading Talents Workstation for Elemental Chinese Materia Medica Innovation and High-Efficiency Utilization (KXJZ[2025]045)
This publication has 72 references indexed in Scilit:
- A Review of ProstatitisJAMA, 2026
- Rutin alleviates bisphenol A‐glycidyl methacrylate‐induced generation of proinflammatory mediators through the MAPK and NF‐κB pathways in macrophagesEnvironmental Toxicology, 2022
- Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in MacrophagesInflammation, 2022
- Tadalafil Alleviates LPS-Induced Inflammation and Oxidative Stress of RWPE-1 Cell by Regulating the Akt/Nrf2 Signaling PathwayInflammation, 2021
- The effect of pirfenidone on rat chronic prostatitis/chronic pelvic pain syndrome and its mechanismsThe Prostate, 2020
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndromeCochrane Database of Systematic Reviews, 2019
- New therapy with XLQ® to suppress chronic prostatitis through its anti‐inflammatory and antioxidative activitiesJournal of Cellular Physiology, 2019
- Quercetin protects against chronic prostatitis in rat model through NF‐κB and MAPK signaling pathwaysThe Prostate, 2018
- Intraurethral injection with LPS: an effective experimental model of prostatic inflammationInflammation Research, 2017
- Anti‐myocardial Ischemia Effect and Components of Litchi Pericarp ExtractsPhytotherapy Research, 2017